Similarly, in a mouse model of GBA-PD, inhibition of glucosylceramide synthase reduced insoluble α-synuclein oligomerization and prevented the accumulation of ubiquitinated proteins (Sardi et al., 2017). Here, UGCG is linked to Parkinson disease.